Nonparticipation Selection Bias in the MOBI-Kids Study.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 10 10 2018
medline: 26 3 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

MOBI-Kids is a 14-country case-control study designed to investigate the potential effects of electromagnetic field exposure from mobile telecommunications devices on brain tumor risk in children and young adults conducted from 2010 to 2016. This work describes differences in cellular telephone use and personal characteristics among interviewed participants and refusers responding to a brief nonrespondent questionnaire. It also assesses the potential impact of nonparticipation selection bias on study findings. We compared nonrespondent questionnaires completed by 77 cases and 498 control refusers with responses from 683 interviewed cases and 1501 controls (suspected appendicitis patients) in six countries (France, Germany, Israel, Italy, Japan, and Spain). We derived selection bias factors and estimated inverse probability of selection weights for use in analysis of MOBI-Kids data. The prevalence of ever-regular use was somewhat higher among interviewed participants than nonrespondent questionnaire respondents 10-14 years of age (68% vs. 62% controls, 63% vs. 48% cases); in those 20-24 years, the prevalence was ≥97%. Interviewed controls and cases in the 15- to 19- and 20- to 24-year-old age groups were more likely to have a time since start of use of 5+ years. Selection bias factors generally indicated a small underestimation in cellular telephone odds ratios (ORs) ranging from 0.96 to 0.97 for ever-regular use and 0.92 to 0.94 for time since start of use (5+ years), but varied in alternative hypothetical scenarios considered. Although limited by small numbers of nonrespondent questionnaire respondents, findings generally indicated a small underestimation in cellular telephone ORs due to selective nonparticipation.

Sections du résumé

BACKGROUND
MOBI-Kids is a 14-country case-control study designed to investigate the potential effects of electromagnetic field exposure from mobile telecommunications devices on brain tumor risk in children and young adults conducted from 2010 to 2016. This work describes differences in cellular telephone use and personal characteristics among interviewed participants and refusers responding to a brief nonrespondent questionnaire. It also assesses the potential impact of nonparticipation selection bias on study findings.
METHODS
We compared nonrespondent questionnaires completed by 77 cases and 498 control refusers with responses from 683 interviewed cases and 1501 controls (suspected appendicitis patients) in six countries (France, Germany, Israel, Italy, Japan, and Spain). We derived selection bias factors and estimated inverse probability of selection weights for use in analysis of MOBI-Kids data.
RESULTS
The prevalence of ever-regular use was somewhat higher among interviewed participants than nonrespondent questionnaire respondents 10-14 years of age (68% vs. 62% controls, 63% vs. 48% cases); in those 20-24 years, the prevalence was ≥97%. Interviewed controls and cases in the 15- to 19- and 20- to 24-year-old age groups were more likely to have a time since start of use of 5+ years. Selection bias factors generally indicated a small underestimation in cellular telephone odds ratios (ORs) ranging from 0.96 to 0.97 for ever-regular use and 0.92 to 0.94 for time since start of use (5+ years), but varied in alternative hypothetical scenarios considered.
CONCLUSIONS
Although limited by small numbers of nonrespondent questionnaire respondents, findings generally indicated a small underestimation in cellular telephone ORs due to selective nonparticipation.

Identifiants

pubmed: 30299406
doi: 10.1097/EDE.0000000000000932
pmc: PMC6276861
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-153

Références

Int J Epidemiol. 2006 Apr;35(2):397-406
pubmed: 16303812
J Expo Sci Environ Epidemiol. 2006 Jul;16(4):371-84
pubmed: 16773122
Eur J Epidemiol. 2007;22(9):647-64
pubmed: 17636416
J Expo Sci Environ Epidemiol. 2009 May;19(4):369-81
pubmed: 18493271
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Ann Epidemiol. 2009 Jan;19(1):33-41
pubmed: 19064187
J Natl Cancer Inst. 2009 Jan 21;101(2):120-3
pubmed: 19141780
Int J Epidemiol. 2010 Jun;39(3):695-8
pubmed: 20483832
Int J Epidemiol. 2010 Jun;39(3):675-94
pubmed: 20483835
Bioelectromagnetics. 2011 Jul;32(5):396-407
pubmed: 21294138
Paediatr Perinat Epidemiol. 2012 May;26(3):276-9
pubmed: 22471687
Am J Epidemiol. 2013 Oct 15;178(8):1337-41
pubmed: 23985129
Int J Epidemiol. 2014 Dec;43(6):1969-85
pubmed: 25080530
Front Public Health. 2014 Sep 23;2:124
pubmed: 25295243
Scand J Public Health. 2015 Mar;43(2):212-9
pubmed: 25592449
Bioelectromagnetics. 2015 Oct;36(7):538-43
pubmed: 26223661
J Clin Epidemiol. 2016 Aug;76:209-17
pubmed: 26968936
Am J Public Health. 2016 Jul;106(7):1227-30
pubmed: 27196652
Am J Epidemiol. 2017 May 15;185(10):865-868
pubmed: 28430833
Am J Epidemiol. 2017 Oct 1;186(7):885-893
pubmed: 28535174
Environ Res. 2018 Aug;165:150-157
pubmed: 29704776
Am J Epidemiol. 1981 Apr;113(4):452-63
pubmed: 6971055

Auteurs

Michelle C Turner (MC)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.

Esther Gracia-Lavedan (E)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Franco Momoli (F)

Ottawa Hospital Research Institute, Ottawa, Canada.
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Chelsea E Langer (CE)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Gemma Castaño-Vinyals (G)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Michael Kundi (M)

Institute of Environmental Health, Medical University of Vienna, Vienna, Austria.

Milena Maule (M)

Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.

Franco Merletti (F)

Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.

Siegal Sadetzki (S)

Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Roel Vermeulen (R)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Alex Albert (A)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Juan Alguacil (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Research Center on Natural Resources, Health and Environment (RENSMA), Huelva University, Huelva, Spain.

Nuria Aragones (N)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Epidemiology Section, Public Health Division, Department of Health, Madrid, Spain.

Francesc Badia (F)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Revital Bruchim (R)

Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.

Gema Carretero (G)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Noriko Kojimahara (N)

Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.

Brigitte Lacour (B)

French National Registry of Childhood Solid Tumors, CHU, Nancy, France.
Inserm U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France.

Maria Morales-Suarez-Varela (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Área de Medicina Preventiva y Salud Pública, Universitat de Valencia, Valencia, Spain.

Katja Radon (K)

Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.

Thomas Remen (T)

French National Registry of Childhood Solid Tumors, CHU, Nancy, France.

Tobias Weinmann (T)

Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.

Naohito Yamaguchi (N)

Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.

Elisabeth Cardis (E)

From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH